Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 9Unknown 5Recruiting 4Withdrawn 3Terminated 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Surgical Wound Infection 1Rectal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Fistula 1Duodenal Neoplasms 1Colorectal Neoplasms 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 439Carboplatin 323Nivolumab 291Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 254Paclitaxel 249Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 169atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Radiosurgery 114Oxaliplatin 114Pemetrexed 113Etoposide 111Fluorouracil 110venetoclax 108fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Anti-Bacterial Agents × Clear all
NCT03631173 2026-04-28

MINIMUM

Oslo University Hospital

Phase NA Active not recruiting
201 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Duodenal Neoplasms, Pancreatic Fistula, Pancreatic Neoplasms

NCT04281667 2022-11-17

MOBILE2

Helsinki University Central Hospital

Phase 4 Active not recruiting
604 enrolled
Gastrointestinal

Rectal Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡